trending Market Intelligence /marketintelligence/en/news-insights/trending/X0y451Geh7eNsPAccE9REQ2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

Pillar Biosciences forms JV with laboratory services provider to lower costs

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Pillar Biosciences forms JV with laboratory services provider to lower costs

Clinical cancer diagnostics company Pillar Biosciences Inc. is forming a joint venture with laboratory services provider China Biotech Services Holdings Ltd.

The joint venture company will provide precision diagnostic products and services in Hong Kong, Macau, South Korea and Southeast Asia.

Gang Song, founder and CEO of Pillar Biosciences, said the joint venture will help decrease costs and increase the accuracy of tests, especially for patients whose samples were being shipped from Hong Kong to the U.S. or other countries for genetic analysis.

The newly created company will also distribute Pillar Biosciences' products including the SLIMamp and PiVAT-based cancer panels in parts of China.

In addition, Hong Kong-based China Biotech Services will take part in Pillar Biosciences' series B financing round that was initially closed in November 2018.

The deal between the two companies was signed Jan. 9 at the JP Morgan Healthcare Conference.